The study of retroviruses have resulted in important discoveries and has lead to insights into basic cellbiology including mechanisms of cell signaling, transcriptional and post transcriptional control of geneexpression, and ultimately cellular transformation and cancer. Project 2 focuses on the human T-cellleukemia virus (HTLV) which is associated primarily with leukemia and highly valuable model of retrovirusinduced cancer. The long-term objective of this highly interactive project is to understand virus-hostinteractions that regulate viral replication post-transcriptionally. We have shown that the post-transcriptionalpositive HTLV regulatory protein, Rex, the focus of the previous application, does not directly contribute tocellular transformation in vitro. We extended our work through collaboration to identify and characterize anovel function of HTLV-1 and HTLV-2 related accessory gene products that act post-transcriptionally asnegative regulators of both Tax and Rex. Our exciting new function assigned to p28 and p30 as posttranscriptionalcontrol regulators provide the basis for the current proposal. We hypothesize that p28-mediated reduction of viral replication in T-lymphocytes and/or the proliferation of T-lymphocytes may permitsurvival of these cells by allowing escape from immune recognition, which would be consistent with thecritical role of HTLV accessory proteins in viral persistence in vivo. We seek to define the post-transcriptionalmechanisms of p28 repressive activity by 1) identifying and characterizing functional domains andbiochemical properties of p28, 2) determining the primary sequence and structure/function of the p28 mRNAtarget, and 3) determining the contribution of p28 in viral replication, lymphocyte activation/transformation,and persistence of the virus and in vivo. Understanding the exact mechanism of action of post-transcriptionalcontrol of p28/p30 ultimately will provide a means for therapeutic targeting of these proteins to eradicateHTLV persistence in the host. Important to this PPG, our findings will contribute to understand how HTLValters T-cell physiology and thus gain insight into the mechanisms of regulating viral replication and the earlyphases of lymphocyte activation and cellular transformation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA100730-06
Application #
7383664
Study Section
Special Emphasis Panel (ZCA1-GRB-S (O1))
Project Start
2008-04-01
Project End
2013-03-31
Budget Start
2008-04-01
Budget End
2009-05-30
Support Year
6
Fiscal Year
2008
Total Cost
$196,973
Indirect Cost
Name
Ohio State University
Department
Type
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Murali, Bhavna; Ren, Qihao; Luo, Xianmin et al. (2018) Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss. Cancer Res 78:5618-5630
Huey, Devra D; Niewiesk, Stefan (2018) Production of Humanized Mice through Stem Cell Transfer. Curr Protoc Mouse Biol 8:17-27
Romeo, Megan; Hutchison, Tetiana; Malu, Aditi et al. (2018) The human T-cell leukemia virus type-1 p30II protein activates p53 and induces the TIGAR and suppresses oncogene-induced oxidative stress during viral carcinogenesis. Virology 518:103-115
Cherian, Mathew A; Olson, Sydney; Sundaramoorthi, Hemalatha et al. (2018) An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia. J Biol Chem 293:6844-6858
Huey, Devra D; Bolon, Brad; La Perle, Krista M D et al. (2018) Role of Wild-type and Recombinant Human T-cell Leukemia Viruses in Lymphoproliferative Disease in Humanized NSG Mice. Comp Med 68:4-14
Pérès, Eléonore; Blin, Juliana; Ricci, Emiliano P et al. (2018) PDZ domain-binding motif of Tax sustains T-cell proliferation in HTLV-1-infected humanized mice. PLoS Pathog 14:e1006933
Panfil, Amanda R; Al-Saleem, Jacob; Howard, Cory M et al. (2018) Stability of the HTLV-1 Antisense-Derived Protein, HBZ, Is Regulated by the E3 Ubiquitin-Protein Ligase, UBR5. Front Microbiol 9:80
Ross, Michael H; Esser, Alison K; Fox, Gregory C et al. (2017) Bone-Induced Expression of Integrin ?3 Enables Targeted Nanotherapy of Breast Cancer Metastases. Cancer Res 77:6299-6312
Esser, Alison K; Rauch, Daniel A; Xiang, Jingyu et al. (2017) HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice. Oncotarget 8:69250-69263
Fontana, Francesca; Ge, Xia; Su, Xinming et al. (2017) Evaluating Acetate Metabolism for Imaging and Targeting in Multiple Myeloma. Clin Cancer Res 23:416-429

Showing the most recent 10 out of 162 publications